US 11638753
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
granted A61KA61K2039/55505A61K2039/55522
Quick answer
US patent 11638753 (Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy) held by PDS Biotechnology Corporation expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PDS Biotechnology Corporation
- Grant date
- Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/55505, A61K2039/55522, A61K2039/55555, A61K2039/55572